Siemens Healthineers reported its Q1 2025 earnings, revealing a revenue of €5.48 billion, surpassing analyst expectations of €5.36 billion. The company also reported an adjusted EBIT of €822 million, exceeding estimates of €803.3 million. For the full fiscal year, Siemens Healthineers provided guidance for adjusted earnings per share (EPS) between €2.35 and €2.50, alongside a forecast for comparable sales growth of 5% to 6%. The positive results indicate strong performance in the medical technology sector, as noted by various analysts.